Healthcare infrastructure and optimizing healthcare processes

Size: px
Start display at page:

Download "Healthcare infrastructure and optimizing healthcare processes"

Transcription

1 1 Healthcare infrastructure and optimizing healthcare processes Dr. Karl-Jürgen Schmitt Siemens Medical Solutions Public Relation and Health Policy Siemens medical Solutions that help

2 2 Healthcare is one of the most important infrastructure components just as... Power... Transportation... ommunication...

3 3 Healthcare as an Economical Factor Healthcare could support the goals of the Lisbon Strategy Europe: Expenses for health: 8.6 % of GDP in EU-15 Employment: around 10 % of European workforce 10% increase in average life expectancy means 0.35% increase of GDP per year* Germany: New Jobs in 2003: Start-ups in (Medical Technology) *Source: Macro-Economics and Health, J. D. Sachs, WHO, 2001

4 4 Healthcare in comparison to other infrastructure components Less than 1 dead person on events Nuclear industry European roads Scheduled flights 1 dead person on to events Road traffic at large hemical industry More than 1 dead person on events Bungee jumping Mountain climbing Healthcare to deaths in the German healthcare system due to wrong medication* Quelle: hirurgen Magazin 2005, *BMGS 2003

5 5 Therefore our common goal should be Quality of are ost By: Innovation Process optimisation

6 IT is key in integrating and optimising workflows throughout the healthcare continuum 6 Med meets IT Prevention / Early Detection Diagnosis Home are Ambulatory are Health Management Mobile are Stationary are are Therapy

7 Significant potential to improve the quality of the healthcare system 7 osts for the insured Adverse Events Actual (w/o Adverse Events ) Ideal Early recognition Diagnosis Therapy Rehab.

8 Quality Quality osts osts Proven Outcomes in medication: Real results with IT-supported processes Preventing 118 potential medication errors monthly. Estimated annual savings: $944 k 73% decrease in erroneous and unclear prescription 8 Virginia, USA Stockholm, Schweden Quality osts 52% reduction of medication turnaround time, 35% reduction of medication errors Ohio, USA Quality osts 96% decrease in medication turnaround time New York, USA

9 9 Quantifying Vascular Risk Screening: A successful method of Telematic Project Internet-based prevention method to quantify vascular risks De-central examination, central and quality controlled reporting by experts Participant with higher risk can subscribe in a Disease Management Program Partner: University Erlangen- Nürnberg, Siemens Insurance Fund and Siemens Medical Solutions Project Outcome ( ) 7,000 Higher Risk 20% = 1,400 Participants Disease Management Program ontinuation in larger cities with up to participants/year

10 A promising project for disease management with IT in Scotland Disease Management Diabetes, Diabetic Retinopathy (DR) 10 Huge Potential Up to 10% of Europeans diabetic 60% of diabetics develop DR DR is leading cause of blindness for individuals > 65 years of age Blindness can be avoided in 90% of DR cases if detected early examinations / year planned 73 locations 5 regional evaluation centers NHS Scotland and Siemens Medical Implementation of an integrated, IT-supported Disease Management Improved... Quality ompliance Processes Use of Resources Outcomes Registration, Invitation Mobile Examination entral Evaluation by Experts Inform Patient

11 NanoMedicine and Molecular Imaging are playing an increasingly important role in the healthcare system of the future 11

12 IT is the enabler for integration of the whole care cycle Molecular Medicine and IT enable integration and clinical use of relevant data Prevention Early Detection Diagnosis Therapy Rehabilitation Nursing Home are 12 Molecular markers for predisposition Gene therapy In vitro-molecular diagnostics with - new technologies (e.g. biochips) - new specific markers In vivo-molecular imaging with - new / combined modalities - new contrast agents - new applications Molecular design of new drugs Individualized therapy based on genetic profiles Molecular in vivo- and in vitro-control of therapy progress Near patientmonitoring of health status

13 Knowledge-based applications and decisions are possible using IT Molecular Medicine and IT enable integration and clinical use of relevant data Prevention Early Detection Diagnosis Therapy Rehabilitation Nursing Home are 13 Genetic Data (Predisposition) Pharmacogenetics Imaging Data Lab Data Anamnesis Medication Pharmacogenomics Therapy ontrol Therapy Monitoring Data ontrol Data Medicine as ustomer Knowledge Standards Electronic Patient Record Pharma as ustomer R&D: Efficient selection of study patients Patient as ustomer Individualized Therapy Industry as ustomer Validation of AD (omputer Aided Diagnosis)

14 Actions Embrace and commit to IT in healthcare Reduce regulations with the goal of an open and transparent competitive healthcare market Achieve a reasonable balance between data privacy regulations and efficient data exchange reate a legal environment for trans-european healthcare delivery Use proven international technical industry standards Establish European benchmarks / best practise sharing Link provider performance to payment: no outcome, no income Include healthcare into European infrastructure funds 14 From Siemens ehealth 2003 Presentation to European Health Ministers in Brussels

15 Healthcare 15 our largest economic factor!... it s a fascinating area!